A study to assess efficacy of collagenase clostridium histolyticum for the treatment of frozen shoulder syndrome

Trial Profile

A study to assess efficacy of collagenase clostridium histolyticum for the treatment of frozen shoulder syndrome

Planning
Phase of Trial: Phase II

Latest Information Update: 10 May 2016

At a glance

  • Drugs Collagenase clostridium histolyticum (Primary)
  • Indications Frozen shoulder
  • Focus Therapeutic Use
  • Sponsors Auxilium Pharmaceuticals
  • Most Recent Events

    • 10 May 2016 Planned initiation date changed from 1 Dec 2015 to 1 Jul 2016, as per BioSpecifics Technologies media release.
    • 09 Nov 2015 According to a Biospecifics Technologies media release, the company confirms that this study will initiate shortly.
    • 12 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top